CS logo
small CS logo
Legacy Good Samaritan Hospital and Medical Center

Portland, Oregon, United States
Medical center in Portland, Oregon
1015 NW 22nd Ave, Portland, OR 97210

About Legacy Good Samaritan Hospital and Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
63
SWOG Cancer Research Network
49
Alliance for Clinical Trials in Oncology
22
NRG Oncology
20
Legacy Health System
11
Radiation Therapy Oncology Group
8
NSABP Foundation Inc
6
ECOG-ACRIN Cancer Research Group
5
Eastern Cooperative Oncology Group
3
GOG Foundation
3
Gynecologic Oncology Group
3
Total Rows: 26

Clinical Trials at Legacy Good Samaritan Hospital and Medical Center


During the past decade, Legacy Good Samaritan Hospital and Medical Center conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 89 clinical trials were completed, i.e. on average, 130.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 34 clinical trials were completed. i.e. 212.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44151511111111111199552288101015151111111188111199Started TrialsCompleted Trails2015201620172018201920202021202205101520
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
Completed
300
The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)
Completed
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
2000-08-01
2012-07-01
Completed
432
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571

Rows per page:

1–100 of 219

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Legacy Good Samaritan Hospital and Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 63 trials, followed by "SWOG Cancer Research Network" with 49 trials sponsored, "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "NRG Oncology" with 20 trials sponsored and "Legacy Health System" with 20 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Legacy Good Samaritan Hospital and Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 121 trials as a collaborator, "NRG Oncology" with 36 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 59 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 63National CancerInstitute (NCI): 63SWOG Cancer ResearchNetwork: 49SWOG Cancer ResearchNetwork: 49Alliance for ClinicalTrials in Oncology: 22Alliance for ClinicalTrials in Oncology: 22NRG Oncology: 20NRG Oncology: 20Legacy Health System: 11Legacy Health System: 11Radiation TherapyOncology Group: 8Radiation TherapyOncology Group: 8NSABP Foundation Inc: 6NSABP Foundation Inc: 6ECOG-ACRIN CancerResearch Group: 5ECOG-ACRIN CancerResearch Group: 5Eastern CooperativeOncology Group: 3Eastern CooperativeOncology Group: 3GOG Foundation: 3GOG Foundation: 3

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 121National CancerInstitute (NCI): 121NRG Oncology: 36NRG Oncology: 36Cancer and LeukemiaGroup B: 12Cancer and LeukemiaGroup B: 12NCIC Clinical Trials Group: 9NCIC Clinical Trials Group: 9SWOG Cancer ResearchNetwork: 7SWOG Cancer ResearchNetwork: 7Canadian Cancer Trials Group: 6Canadian Cancer Trials Group: 6Radiation TherapyOncology Group: 6Radiation TherapyOncology Group: 6North Central CancerTreatment Group: 5North Central CancerTreatment Group: 5Eastern CooperativeOncology Group: 4Eastern CooperativeOncology Group: 4National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 3National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 3

Clinical Trials Conditions at Legacy Good Samaritan Hospital and Medical Center


According to Clinical.Site data, the most researched conditions in "Legacy Good Samaritan Hospital and Medical Center" are "Breast Cancer" (24 trials), "Recurrent Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Lymphoma" (8 trials) and "Fallopian Tube Transitional Cell Carcinoma" (7 trials). Many other conditions were trialed in "Legacy Good Samaritan Hospital and Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Legacy Good Samaritan Hospital and Medical Center


Most popular intervention types in "Legacy Good Samaritan Hospital and Medical Center" are "Drug" (162 trials), "Other" (104 trials), "Radiation" (60 trials), "Biological" (59 trials) and "Procedure" (46 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (52 trials), "Quality-of-Life Assessment" (43 trials), "Questionnaire Administration" (24 trials), "Paclitaxel" (22 trials) and "Carboplatin" (16 trials). Other intervention names were less common.

Clinical Trials Genders at Legacy Good Samaritan Hospital and Medical Center


The vast majority of trials in "Legacy Good Samaritan Hospital and Medical Center" are 148 trials for "All" genders, 58 trials for "Female" genders and 13 trials for "Male" genders.

Clinical Trials Status at Legacy Good Samaritan Hospital and Medical Center


Currently, there are NaN active trials in "Legacy Good Samaritan Hospital and Medical Center". undefined are not yet recruiting, 25 are recruiting, 70 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 100 completed trials in Legacy Good Samaritan Hospital and Medical Center, 3 suspended trials, and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Legacy Good Samaritan Hospital and Medical Center, 8 "Phase 1" clinical trials were conducted, 79 "Phase 2" clinical trials and 120 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 19 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 120Phase 3: 120Phase 2: 79Phase 2: 79Not Applicable: 19Not Applicable: 19Phase 1: 8Phase 1: 8Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 100Completed: 100Active, not recruiting: 70Active, not recruiting: 70Recruiting: 25Recruiting: 25Terminated: 14Terminated: 14Unknown status: 7Unknown status: 7Suspended: 3Suspended: 3